Suppr超能文献

慢性铜绿假单胞菌感染在囊性纤维化患者中的变化率:一项基于人群的队列研究。

Changing Rates of Chronic Pseudomonas aeruginosa Infections in Cystic Fibrosis: A Population-Based Cohort Study.

机构信息

Department of Medicine, University of Washington, Seattle.

Department of Medicine, University of Calgary, Alberta, Canada.

出版信息

Clin Infect Dis. 2018 Sep 14;67(7):1089-1095. doi: 10.1093/cid/ciy215.

Abstract

BACKGROUND

Chronic Pseudomonas aeruginosa lung infection is associated with significant morbidity and mortality in cystic fibrosis (CF). It is not known whether recent advances in care have affected the rates of chronic infection. We aimed to determine if the rates of developing new chronic P. aeruginosa infection among adolescents and adults with CF significantly changed over time.

METHODS

The cohort consisted of individuals with CF followed in the Cystic Fibrosis Foundation Patient Registry aged ≥13 years without chronic P. aeruginosa at baseline. Multivariable regression models accounting for within-patient correlation were used to assess the change in rate of developing chronic P. aeruginosa infection between 2003 and 2012.

RESULTS

A total of 15504 individuals were followed for a median of 5 (interquartile range, 2-9) years. The annual rates of developing new chronic P. aeruginosa decreased from 14.3% in 2003 to 6.4% in 2012. After adjusting for potential confounders, relative risk (RR) of developing chronic P. aeruginosa infection decreased significantly over time compared to 2003 (P value test of trend < .001). Compared with 2003, the RR of developing chronic P. aeruginosa infection in 2012 was 0.33 (95% confidence interval, 0.30-0.37). No significant increases in risk of chronic infections with other major CF bacterial pathogens relative to 2003 were identified.

CONCLUSIONS

Among individuals with CF, a significant decrease in the risk and rates of developing chronic P. aeruginosa infection between 2003 and 2012 was observed. Whether this decline results in changes in clinical outcomes warrants further exploration.

摘要

背景

慢性铜绿假单胞菌肺部感染与囊性纤维化(CF)患者的高发病率和高死亡率密切相关。目前尚不清楚最近的治疗进展是否影响了慢性感染的发生率。我们旨在确定 CF 青少年和成年患者中新发慢性铜绿假单胞菌感染的发生率是否随时间显著变化。

方法

该队列由在囊性纤维化基金会患者登记处接受随访的年龄≥13 岁且基线时无慢性铜绿假单胞菌感染的 CF 患者组成。使用考虑到患者内相关性的多变量回归模型来评估 2003 年至 2012 年期间慢性铜绿假单胞菌感染发展率的变化。

结果

共有 15504 名患者接受了中位 5(四分位距,2-9)年的随访。新发慢性铜绿假单胞菌感染的年发生率从 2003 年的 14.3%降至 2012 年的 6.4%。在调整了潜在混杂因素后,与 2003 年相比,慢性铜绿假单胞菌感染的发病相对风险(RR)随时间显著降低(趋势检验 P 值<0.001)。与 2003 年相比,2012 年发生慢性铜绿假单胞菌感染的 RR 为 0.33(95%置信区间,0.30-0.37)。与 2003 年相比,未发现其他主要 CF 细菌病原体引起的慢性感染风险显著增加。

结论

在 CF 患者中,2003 年至 2012 年间慢性铜绿假单胞菌感染的风险和发生率显著下降。这种下降是否会导致临床结局的变化,尚需进一步探讨。

相似文献

3
Change in Pseudomonas aeruginosa prevalence in cystic fibrosis adults over time.
BMC Pulm Med. 2016 Dec 7;16(1):176. doi: 10.1186/s12890-016-0333-y.
4
Mouse models of chronic lung infection with Pseudomonas aeruginosa: models for the study of cystic fibrosis.
Pediatr Pulmonol. 2000 Nov;30(5):413-24. doi: 10.1002/1099-0496(200011)30:5<413::aid-ppul8>3.0.co;2-9.
6
Pseudomonas aeruginosa in cystic fibrosis patients with G551D-CFTR treated with ivacaftor.
Clin Infect Dis. 2015 Mar 1;60(5):703-12. doi: 10.1093/cid/ciu944. Epub 2014 Nov 25.
8
DCTN4 as a modifier of chronic Pseudomonas aeruginosa infection in cystic fibrosis.
Clin Respir J. 2016 Nov;10(6):777-783. doi: 10.1111/crj.12288. Epub 2015 Apr 15.
9
Chronic Pseudomonas aeruginosa infection and respiratory muscle impairment in cystic fibrosis.
Respir Care. 2014 Mar;59(3):363-70. doi: 10.4187/respcare.02549. Epub 2013 Aug 27.
10
Pseudomonas aeruginosa in vitro phenotypes distinguish cystic fibrosis infection stages and outcomes.
Am J Respir Crit Care Med. 2014 Aug 1;190(3):289-97. doi: 10.1164/rccm.201404-0681OC.

引用本文的文献

2
Time-resolved dual transcriptomics of biofilm formation in cystic fibrosis.
Biofilm. 2025 Jul 2;10:100301. doi: 10.1016/j.bioflm.2025.100301. eCollection 2025 Dec.
4
Difficult-to-Treat Infections in Critically Ill Patients: A Comprehensive Review and Treatment Proposal.
Antibiotics (Basel). 2025 Feb 11;14(2):178. doi: 10.3390/antibiotics14020178.
6
Clinical epidemiology and impact of Haemophilus influenzae airway infections in adults with cystic fibrosis.
BMC Infect Dis. 2024 Oct 27;24(1):1209. doi: 10.1186/s12879-024-10050-7.
10
A Novel Zinc (II) Porphyrin Is Synergistic with PEV2 Bacteriophage against Infections.
Antibiotics (Basel). 2023 Apr 10;12(4):735. doi: 10.3390/antibiotics12040735.

本文引用的文献

1
Change in Pseudomonas aeruginosa prevalence in cystic fibrosis adults over time.
BMC Pulm Med. 2016 Dec 7;16(1):176. doi: 10.1186/s12890-016-0333-y.
2
The changing prevalence of pulmonary infection in adults with cystic fibrosis: A longitudinal analysis.
J Cyst Fibros. 2017 Jan;16(1):70-77. doi: 10.1016/j.jcf.2016.07.010. Epub 2016 Aug 8.
3
The Cystic Fibrosis Foundation Patient Registry. Design and Methods of a National Observational Disease Registry.
Ann Am Thorac Soc. 2016 Jul;13(7):1173-9. doi: 10.1513/AnnalsATS.201511-781OC.
4
Changing Epidemiology of the Respiratory Bacteriology of Patients With Cystic Fibrosis.
Chest. 2016 Feb;149(2):390-400. doi: 10.1378/chest.15-0676. Epub 2016 Jan 12.
5
Impact of Sustained Eradication of New Pseudomonas aeruginosa Infection on Long-term Outcomes in Cystic Fibrosis.
Clin Infect Dis. 2015 Sep 1;61(5):707-15. doi: 10.1093/cid/civ377. Epub 2015 May 13.
6
Eradication of Pseudomonas aeruginosa in adults with cystic fibrosis.
BMJ Open Respir Res. 2014 Apr 23;1(1):e000021. doi: 10.1136/bmjresp-2014-000021. eCollection 2014.
7
Pseudomonas aeruginosa in cystic fibrosis patients with G551D-CFTR treated with ivacaftor.
Clin Infect Dis. 2015 Mar 1;60(5):703-12. doi: 10.1093/cid/ciu944. Epub 2014 Nov 25.
9
Pseudomonas aeruginosa in vitro phenotypes distinguish cystic fibrosis infection stages and outcomes.
Am J Respir Crit Care Med. 2014 Aug 1;190(3):289-97. doi: 10.1164/rccm.201404-0681OC.
10
CFTR genotype and clinical outcomes of adult patients carried as cystic fibrosis disease.
Gene. 2014 May 1;540(2):183-90. doi: 10.1016/j.gene.2014.02.040. Epub 2014 Feb 26.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验